NON-CUTANEOUS MELANOMA
Clinical trials for NON-CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new NON-CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for NON-CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major cancer trial tests new drug to stop deadly Melanoma's return
Disease control OngoingThis large, late-stage trial is testing if a drug called pembrolizumab works better than current standard treatments to prevent melanoma skin cancer from coming back or spreading after surgery. It enrolled over 1,300 patients with high-risk stage III or IV melanoma whose tumors w…
Matched conditions: NON-CUTANEOUS MELANOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
First human test: using Patients' own immune cells to fight advanced skin cancer
Disease control OngoingThis early-stage study is testing a personalized treatment called TBio-4101 for people with advanced melanoma that hasn't responded to standard therapies. Doctors take immune cells from a patient's tumor, grow them in large numbers in a lab, and then infuse them back into the pat…
Matched conditions: NON-CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC